English
简体中文
Total: £ 56.28
Published Date: 2025-12-02 | Pages: 128 | Tables: 132 | Pharma & Healthcare
The global market for Sulfonylureas for Type 2 Diabetes was valued at US$ 25325 million in the year 2024 and is projected to reach a revised size of US$ 35391 million by 2031, growing at a CAGR of 4.9% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sulfonylureas for Type 2 Diabetes competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2024, global Sulfonylureas for Type 2 Diabetes production reached approximately 4336.42 M Units, with an average global market price of around 5.84 USD per Unit. The global prevalence of type 2 diabetes continues to rise, with an expanding number of high-risk groups such as the middle-aged and elderly, and obese individuals. Some hypoglycemic drugs have limited efficacy in controlling blood sugar or significant adverse reactions. Sulfonylureas, however, balance the core needs of ""achieving therapeutic goals"" and ""safe medication"" with their potent blood sugar-lowering effects and optimized safety profile. They are particularly suitable for high-risk groups such as the middle-aged and elderly, and those with underlying medical conditions, eliminating clinical concerns about ""unstable blood sugar control"" or ""excessive risk."" As a classic oral hypoglycemic agent for the treatment of type 2 diabetes, sulfonylureas precisely address the core pain points in clinical treatment, and their market potential continues to expand against the backdrop of a continuously rising global demand for diabetes prevention and control.
Sulfonylureas are a class of oral medications used primarily to treat Type 2 Diabetes Mellitus. They are among the oldest and most widely used anti-diabetic drugs, known for their high efficacy and relatively low cost.Sulfonylureas for Type 2 Diabetes are mainly divided into Glibenclamide, Glipizide, Gliclazide, Glizidone, and Glimepiride, which have advantages such as strong hypoglycemic effect, milder side effects, and more convenient dosing frequency.
The upstream raw materials for Sulfonylureas for Type 2 Diabetes mainly include active ingredients such as glibenclamide, glipizide, gliclazide, glimepiride, and glimepiride. Typical suppliers include AGC Pharma Chemicals, ICROM, Gedeon Richter, and Dr. Reddy's Laboratories. Downstream applications are mainly in hospitals and pharmacies. The single-line production capacity of Sulfonylureas for Type 2 Diabetes varies significantly depending on the dosage form and production scale, with annual production capacity typically ranging from 50 million to 150 million tablets, and gross profit margins usually between 30% and 50%.
North American market for Sulfonylureas for Type 2 Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sulfonylureas for Type 2 Diabetes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Sulfonylureas for Type 2 Diabetes include Sanofi, Pfizer, Teva, AdvaCare Pharma, Krka, Lupin Healthcare, Viatris (Mylan), Apotex Corporation, Hoechst Canada, Hikma Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sulfonylureas for Type 2 Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sulfonylureas for Type 2 Diabetes.
The Sulfonylureas for Type 2 Diabetes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sulfonylureas for Type 2 Diabetes market comprehensively. Regional market sizes, concerning products by Type, by Application, by Patent and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sulfonylureas for Type 2 Diabetes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Patent and by regions.
By Company
Sanofi
Pfizer
Teva
AdvaCare Pharma
Krka
Lupin Healthcare
Viatris (Mylan)
Apotex Corporation
Hoechst Canada
Hikma Pharmaceuticals
Servier Laboratories
Aurobindo Pharma
Zydus Cadila Healthcare
Accord Healthcare
Taj Pharma
Boehringer Ingelheim
Qingdao Double Whale Pharmaceutical
CHANGZHOU SUNLIGHT PHARMACEUTICAL
Zhejiang Shapuaisi Pharmaceutical
DISHA PHARMACEUTICAL GROUP
Shandong Lukang Pharmaceutical
Beijing Jingfeng pharmaceutical
Suzhou Zhonghua Pharmaceutical Industry
Shanghai SINE United Pharmaceuticals
Zhuhai United Pharmaceutical
Changzhou Siyao Pharmaceuticals
Shijiazhuang Yiling Pharmaceutical
Jiangsu Vanguard Pharmaceutical
China Resources Shuanghe Pharmaceutical
TIPR PHARMACEUTICAL
Jilin Jinheng Pharmaceutical
Wanbang Biopharmaceuticals
Cspc Holdings Company
Segment by Type
Glibenclamide
Glipizide
Gliclazide
Glizidone
Glimepiride
Segment by Patent
Original Drug
Generic Drug
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sulfonylureas for Type 2 Diabetes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sulfonylureas for Type 2 Diabetes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Sulfonylureas for Type 2 Diabetes Market Overview
1.1 Product Definition
1.2 Sulfonylureas for Type 2 Diabetes by Type
1.2.1 Global Sulfonylureas for Type 2 Diabetes Market Value Comparison by Type (2024 VS 2031)
1.2.2 Glibenclamide
1.2.3 Glipizide
1.2.4 Gliclazide
1.2.5 Glizidone
1.2.6 Glimepiride
1.3 Sulfonylureas for Type 2 Diabetes by Patent
1.3.1 Global Sulfonylureas for Type 2 Diabetes Market Value Comparison by Patent: 2024 VS 2031
1.3.2 Original Drug
1.3.3 Generic Drug
1.4 Sulfonylureas for Type 2 Diabetes by Application
1.4.1 Global Sulfonylureas for Type 2 Diabetes Market Value by Application (2024 VS 2031)
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Sulfonylureas for Type 2 Diabetes Market Size Estimates and Forecasts
1.5.1 Global Sulfonylureas for Type 2 Diabetes Revenue 2020-2031
1.5.2 Global Sulfonylureas for Type 2 Diabetes Sales 2020-2031
1.5.3 Global Sulfonylureas for Type 2 Diabetes Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 Sulfonylureas for Type 2 Diabetes Market Competition by Manufacturers
2.1 Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sulfonylureas for Type 2 Diabetes Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sulfonylureas for Type 2 Diabetes, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sulfonylureas for Type 2 Diabetes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sulfonylureas for Type 2 Diabetes, Product Type & Application
2.7 Global Key Manufacturers of Sulfonylureas for Type 2 Diabetes, Date of Enter into This Industry
2.8 Global Sulfonylureas for Type 2 Diabetes Market Competitive Situation and Trends
2.8.1 Global Sulfonylureas for Type 2 Diabetes Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sulfonylureas for Type 2 Diabetes Players Market Share by Revenue
2.8.3 Global Sulfonylureas for Type 2 Diabetes Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sulfonylureas for Type 2 Diabetes Market Scenario by Region
3.1 Global Sulfonylureas for Type 2 Diabetes Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sulfonylureas for Type 2 Diabetes Sales by Region: 2020-2031
3.2.1 Global Sulfonylureas for Type 2 Diabetes Sales by Region: 2020-2025
3.2.2 Global Sulfonylureas for Type 2 Diabetes Sales by Region: 2026-2031
3.3 Global Sulfonylureas for Type 2 Diabetes Revenue by Region: 2020-2031
3.3.1 Global Sulfonylureas for Type 2 Diabetes Revenue by Region: 2020-2025
3.3.2 Global Sulfonylureas for Type 2 Diabetes Revenue by Region: 2026-2031
3.4 North America Sulfonylureas for Type 2 Diabetes Market Facts & Figures by Country
3.4.1 North America Sulfonylureas for Type 2 Diabetes Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sulfonylureas for Type 2 Diabetes Sales by Country (2020-2031)
3.4.3 North America Sulfonylureas for Type 2 Diabetes Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sulfonylureas for Type 2 Diabetes Market Facts & Figures by Country
3.5.1 Europe Sulfonylureas for Type 2 Diabetes Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sulfonylureas for Type 2 Diabetes Sales by Country (2020-2031)
3.5.3 Europe Sulfonylureas for Type 2 Diabetes Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sulfonylureas for Type 2 Diabetes Market Facts & Figures by Region
3.6.1 Asia Pacific Sulfonylureas for Type 2 Diabetes Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sulfonylureas for Type 2 Diabetes Sales by Region (2020-2031)
3.6.3 Asia Pacific Sulfonylureas for Type 2 Diabetes Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sulfonylureas for Type 2 Diabetes Market Facts & Figures by Country
3.7.1 Latin America Sulfonylureas for Type 2 Diabetes Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sulfonylureas for Type 2 Diabetes Sales by Country (2020-2031)
3.7.3 Latin America Sulfonylureas for Type 2 Diabetes Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sulfonylureas for Type 2 Diabetes Market Facts & Figures by Country
3.8.1 Middle East and Africa Sulfonylureas for Type 2 Diabetes Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sulfonylureas for Type 2 Diabetes Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sulfonylureas for Type 2 Diabetes Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sulfonylureas for Type 2 Diabetes Sales by Type (2020-2031)
4.1.1 Global Sulfonylureas for Type 2 Diabetes Sales by Type (2020-2025)
4.1.2 Global Sulfonylureas for Type 2 Diabetes Sales by Type (2026-2031)
4.1.3 Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Type (2020-2031)
4.2 Global Sulfonylureas for Type 2 Diabetes Revenue by Type (2020-2031)
4.2.1 Global Sulfonylureas for Type 2 Diabetes Revenue by Type (2020-2025)
4.2.2 Global Sulfonylureas for Type 2 Diabetes Revenue by Type (2026-2031)
4.2.3 Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Type (2020-2031)
4.3 Global Sulfonylureas for Type 2 Diabetes Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sulfonylureas for Type 2 Diabetes Sales by Application (2020-2031)
5.1.1 Global Sulfonylureas for Type 2 Diabetes Sales by Application (2020-2025)
5.1.2 Global Sulfonylureas for Type 2 Diabetes Sales by Application (2026-2031)
5.1.3 Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Application (2020-2031)
5.2 Global Sulfonylureas for Type 2 Diabetes Revenue by Application (2020-2031)
5.2.1 Global Sulfonylureas for Type 2 Diabetes Revenue by Application (2020-2025)
5.2.2 Global Sulfonylureas for Type 2 Diabetes Revenue by Application (2026-2031)
5.2.3 Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Application (2020-2031)
5.3 Global Sulfonylureas for Type 2 Diabetes Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Sulfonylureas for Type 2 Diabetes Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Sulfonylureas for Type 2 Diabetes Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Sulfonylureas for Type 2 Diabetes Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 AdvaCare Pharma
6.4.1 AdvaCare Pharma Company Information
6.4.2 AdvaCare Pharma Description and Business Overview
6.4.3 AdvaCare Pharma Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AdvaCare Pharma Sulfonylureas for Type 2 Diabetes Product Portfolio
6.4.5 AdvaCare Pharma Recent Developments/Updates
6.5 Krka
6.5.1 Krka Company Information
6.5.2 Krka Description and Business Overview
6.5.3 Krka Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Krka Sulfonylureas for Type 2 Diabetes Product Portfolio
6.5.5 Krka Recent Developments/Updates
6.6 Lupin Healthcare
6.6.1 Lupin Healthcare Company Information
6.6.2 Lupin Healthcare Description and Business Overview
6.6.3 Lupin Healthcare Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lupin Healthcare Sulfonylureas for Type 2 Diabetes Product Portfolio
6.6.5 Lupin Healthcare Recent Developments/Updates
6.7 Viatris (Mylan)
6.7.1 Viatris (Mylan) Company Information
6.7.2 Viatris (Mylan) Description and Business Overview
6.7.3 Viatris (Mylan) Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Viatris (Mylan) Sulfonylureas for Type 2 Diabetes Product Portfolio
6.7.5 Viatris (Mylan) Recent Developments/Updates
6.8 Apotex Corporation
6.8.1 Apotex Corporation Company Information
6.8.2 Apotex Corporation Description and Business Overview
6.8.3 Apotex Corporation Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Apotex Corporation Sulfonylureas for Type 2 Diabetes Product Portfolio
6.8.5 Apotex Corporation Recent Developments/Updates
6.9 Hoechst Canada
6.9.1 Hoechst Canada Company Information
6.9.2 Hoechst Canada Description and Business Overview
6.9.3 Hoechst Canada Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hoechst Canada Sulfonylureas for Type 2 Diabetes Product Portfolio
6.9.5 Hoechst Canada Recent Developments/Updates
6.10 Hikma Pharmaceuticals
6.10.1 Hikma Pharmaceuticals Company Information
6.10.2 Hikma Pharmaceuticals Description and Business Overview
6.10.3 Hikma Pharmaceuticals Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hikma Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Portfolio
6.10.5 Hikma Pharmaceuticals Recent Developments/Updates
6.11 Servier Laboratories
6.11.1 Servier Laboratories Company Information
6.11.2 Servier Laboratories Description and Business Overview
6.11.3 Servier Laboratories Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Servier Laboratories Sulfonylureas for Type 2 Diabetes Product Portfolio
6.11.5 Servier Laboratories Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Company Information
6.12.2 Aurobindo Pharma Description and Business Overview
6.12.3 Aurobindo Pharma Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Aurobindo Pharma Sulfonylureas for Type 2 Diabetes Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Zydus Cadila Healthcare
6.13.1 Zydus Cadila Healthcare Company Information
6.13.2 Zydus Cadila Healthcare Description and Business Overview
6.13.3 Zydus Cadila Healthcare Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Zydus Cadila Healthcare Sulfonylureas for Type 2 Diabetes Product Portfolio
6.13.5 Zydus Cadila Healthcare Recent Developments/Updates
6.14 Accord Healthcare
6.14.1 Accord Healthcare Company Information
6.14.2 Accord Healthcare Description and Business Overview
6.14.3 Accord Healthcare Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Accord Healthcare Sulfonylureas for Type 2 Diabetes Product Portfolio
6.14.5 Accord Healthcare Recent Developments/Updates
6.15 Taj Pharma
6.15.1 Taj Pharma Company Information
6.15.2 Taj Pharma Description and Business Overview
6.15.3 Taj Pharma Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Taj Pharma Sulfonylureas for Type 2 Diabetes Product Portfolio
6.15.5 Taj Pharma Recent Developments/Updates
6.16 Boehringer Ingelheim
6.16.1 Boehringer Ingelheim Company Information
6.16.2 Boehringer Ingelheim Description and Business Overview
6.16.3 Boehringer Ingelheim Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Boehringer Ingelheim Sulfonylureas for Type 2 Diabetes Product Portfolio
6.16.5 Boehringer Ingelheim Recent Developments/Updates
6.17 Qingdao Double Whale Pharmaceutical
6.17.1 Qingdao Double Whale Pharmaceutical Company Information
6.17.2 Qingdao Double Whale Pharmaceutical Description and Business Overview
6.17.3 Qingdao Double Whale Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Qingdao Double Whale Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Portfolio
6.17.5 Qingdao Double Whale Pharmaceutical Recent Developments/Updates
6.18 CHANGZHOU SUNLIGHT PHARMACEUTICAL
6.18.1 CHANGZHOU SUNLIGHT PHARMACEUTICAL Company Information
6.18.2 CHANGZHOU SUNLIGHT PHARMACEUTICAL Description and Business Overview
6.18.3 CHANGZHOU SUNLIGHT PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.18.4 CHANGZHOU SUNLIGHT PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Product Portfolio
6.18.5 CHANGZHOU SUNLIGHT PHARMACEUTICAL Recent Developments/Updates
6.19 Zhejiang Shapuaisi Pharmaceutical
6.19.1 Zhejiang Shapuaisi Pharmaceutical Company Information
6.19.2 Zhejiang Shapuaisi Pharmaceutical Description and Business Overview
6.19.3 Zhejiang Shapuaisi Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Zhejiang Shapuaisi Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Portfolio
6.19.5 Zhejiang Shapuaisi Pharmaceutical Recent Developments/Updates
6.20 DISHA PHARMACEUTICAL GROUP
6.20.1 DISHA PHARMACEUTICAL GROUP Company Information
6.20.2 DISHA PHARMACEUTICAL GROUP Description and Business Overview
6.20.3 DISHA PHARMACEUTICAL GROUP Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.20.4 DISHA PHARMACEUTICAL GROUP Sulfonylureas for Type 2 Diabetes Product Portfolio
6.20.5 DISHA PHARMACEUTICAL GROUP Recent Developments/Updates
6.21 Shandong Lukang Pharmaceutical
6.21.1 Shandong Lukang Pharmaceutical Company Information
6.21.2 Shandong Lukang Pharmaceutical Description and Business Overview
6.21.3 Shandong Lukang Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Shandong Lukang Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Portfolio
6.21.5 Shandong Lukang Pharmaceutical Recent Developments/Updates
6.22 Beijing Jingfeng pharmaceutical
6.22.1 Beijing Jingfeng pharmaceutical Company Information
6.22.2 Beijing Jingfeng pharmaceutical Description and Business Overview
6.22.3 Beijing Jingfeng pharmaceutical Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Beijing Jingfeng pharmaceutical Sulfonylureas for Type 2 Diabetes Product Portfolio
6.22.5 Beijing Jingfeng pharmaceutical Recent Developments/Updates
6.23 Suzhou Zhonghua Pharmaceutical Industry
6.23.1 Suzhou Zhonghua Pharmaceutical Industry Company Information
6.23.2 Suzhou Zhonghua Pharmaceutical Industry Description and Business Overview
6.23.3 Suzhou Zhonghua Pharmaceutical Industry Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Suzhou Zhonghua Pharmaceutical Industry Sulfonylureas for Type 2 Diabetes Product Portfolio
6.23.5 Suzhou Zhonghua Pharmaceutical Industry Recent Developments/Updates
6.24 Shanghai SINE United Pharmaceuticals
6.24.1 Shanghai SINE United Pharmaceuticals Company Information
6.24.2 Shanghai SINE United Pharmaceuticals Description and Business Overview
6.24.3 Shanghai SINE United Pharmaceuticals Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Shanghai SINE United Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Portfolio
6.24.5 Shanghai SINE United Pharmaceuticals Recent Developments/Updates
6.25 Zhuhai United Pharmaceutical
6.25.1 Zhuhai United Pharmaceutical Company Information
6.25.2 Zhuhai United Pharmaceutical Description and Business Overview
6.25.3 Zhuhai United Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Zhuhai United Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Portfolio
6.25.5 Zhuhai United Pharmaceutical Recent Developments/Updates
6.26 Changzhou Siyao Pharmaceuticals
6.26.1 Changzhou Siyao Pharmaceuticals Company Information
6.26.2 Changzhou Siyao Pharmaceuticals Description and Business Overview
6.26.3 Changzhou Siyao Pharmaceuticals Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Changzhou Siyao Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product Portfolio
6.26.5 Changzhou Siyao Pharmaceuticals Recent Developments/Updates
6.27 Shijiazhuang Yiling Pharmaceutical
6.27.1 Shijiazhuang Yiling Pharmaceutical Company Information
6.27.2 Shijiazhuang Yiling Pharmaceutical Description and Business Overview
6.27.3 Shijiazhuang Yiling Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Shijiazhuang Yiling Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Portfolio
6.27.5 Shijiazhuang Yiling Pharmaceutical Recent Developments/Updates
6.28 Jiangsu Vanguard Pharmaceutical
6.28.1 Jiangsu Vanguard Pharmaceutical Company Information
6.28.2 Jiangsu Vanguard Pharmaceutical Description and Business Overview
6.28.3 Jiangsu Vanguard Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.28.4 Jiangsu Vanguard Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Portfolio
6.28.5 Jiangsu Vanguard Pharmaceutical Recent Developments/Updates
6.29 China Resources Shuanghe Pharmaceutical
6.29.1 China Resources Shuanghe Pharmaceutical Company Information
6.29.2 China Resources Shuanghe Pharmaceutical Description and Business Overview
6.29.3 China Resources Shuanghe Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.29.4 China Resources Shuanghe Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Portfolio
6.29.5 China Resources Shuanghe Pharmaceutical Recent Developments/Updates
6.30 TIPR PHARMACEUTICAL
6.30.1 TIPR PHARMACEUTICAL Company Information
6.30.2 TIPR PHARMACEUTICAL Description and Business Overview
6.30.3 TIPR PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.30.4 TIPR PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Product Portfolio
6.30.5 TIPR PHARMACEUTICAL Recent Developments/Updates
6.31 Jilin Jinheng Pharmaceutical
6.31.1 Jilin Jinheng Pharmaceutical Company Information
6.31.2 Jilin Jinheng Pharmaceutical Description and Business Overview
6.31.3 Jilin Jinheng Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.31.4 Jilin Jinheng Pharmaceutical Sulfonylureas for Type 2 Diabetes Product Portfolio
6.31.5 Jilin Jinheng Pharmaceutical Recent Developments/Updates
6.32 Wanbang Biopharmaceuticals
6.32.1 Wanbang Biopharmaceuticals Company Information
6.32.2 Wanbang Biopharmaceuticals Description and Business Overview
6.32.3 Wanbang Biopharmaceuticals Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.32.4 Wanbang Biopharmaceuticals Sulfonylureas for Type 2 Diabetes Product Portfolio
6.32.5 Wanbang Biopharmaceuticals Recent Developments/Updates
6.33 Cspc Holdings Company
6.33.1 Cspc Holdings Company Company Information
6.33.2 Cspc Holdings Company Description and Business Overview
6.33.3 Cspc Holdings Company Sulfonylureas for Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)
6.33.4 Cspc Holdings Company Sulfonylureas for Type 2 Diabetes Product Portfolio
6.33.5 Cspc Holdings Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sulfonylureas for Type 2 Diabetes Industry Chain Analysis
7.2 Sulfonylureas for Type 2 Diabetes Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sulfonylureas for Type 2 Diabetes Production Mode & Process Analysis
7.4 Sulfonylureas for Type 2 Diabetes Sales and Marketing
7.4.1 Sulfonylureas for Type 2 Diabetes Sales Channels
7.4.2 Sulfonylureas for Type 2 Diabetes Distributors
7.5 Sulfonylureas for Type 2 Diabetes Customer Analysis
8 Sulfonylureas for Type 2 Diabetes Market Dynamics
8.1 Sulfonylureas for Type 2 Diabetes Industry Trends
8.2 Sulfonylureas for Type 2 Diabetes Market Drivers
8.3 Sulfonylureas for Type 2 Diabetes Market Challenges
8.4 Sulfonylureas for Type 2 Diabetes Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Sulfonylureas for Type 2 Diabetes Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Sulfonylureas for Type 2 Diabetes Market Value by Patent, (US$ Million) & (2024 VS 2031)
Table 3. Global Sulfonylureas for Type 2 Diabetes Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global Sulfonylureas for Type 2 Diabetes Market Competitive Situation by Manufacturers in 2024
Table 5. Global Sulfonylureas for Type 2 Diabetes Sales (K Units) of Key Manufacturers (2020-2025)
Table 6. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Sulfonylureas for Type 2 Diabetes Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global Sulfonylureas for Type 2 Diabetes Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market Sulfonylureas for Type 2 Diabetes Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of Sulfonylureas for Type 2 Diabetes, Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of Sulfonylureas for Type 2 Diabetes, Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of Sulfonylureas for Type 2 Diabetes, Product Type & Application
Table 13. Global Key Manufacturers of Sulfonylureas for Type 2 Diabetes, Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Sulfonylureas for Type 2 Diabetes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulfonylureas for Type 2 Diabetes as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Sulfonylureas for Type 2 Diabetes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Sulfonylureas for Type 2 Diabetes Sales by Region (2020-2025) & (K Units)
Table 19. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Region (2020-2025)
Table 20. Global Sulfonylureas for Type 2 Diabetes Sales by Region (2026-2031) & (K Units)
Table 21. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Region (2026-2031)
Table 22. Global Sulfonylureas for Type 2 Diabetes Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Region (2020-2025)
Table 24. Global Sulfonylureas for Type 2 Diabetes Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Region (2026-2031)
Table 26. North America Sulfonylureas for Type 2 Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America Sulfonylureas for Type 2 Diabetes Sales by Country (2020-2025) & (K Units)
Table 28. North America Sulfonylureas for Type 2 Diabetes Sales by Country (2026-2031) & (K Units)
Table 29. North America Sulfonylureas for Type 2 Diabetes Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America Sulfonylureas for Type 2 Diabetes Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe Sulfonylureas for Type 2 Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe Sulfonylureas for Type 2 Diabetes Sales by Country (2020-2025) & (K Units)
Table 33. Europe Sulfonylureas for Type 2 Diabetes Sales by Country (2026-2031) & (K Units)
Table 34. Europe Sulfonylureas for Type 2 Diabetes Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe Sulfonylureas for Type 2 Diabetes Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Sulfonylureas for Type 2 Diabetes Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Sulfonylureas for Type 2 Diabetes Sales by Region (2020-2025) & (K Units)
Table 38. Asia Pacific Sulfonylureas for Type 2 Diabetes Sales by Region (2026-2031) & (K Units)
Table 39. Asia Pacific Sulfonylureas for Type 2 Diabetes Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific Sulfonylureas for Type 2 Diabetes Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America Sulfonylureas for Type 2 Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America Sulfonylureas for Type 2 Diabetes Sales by Country (2020-2025) & (K Units)
Table 43. Latin America Sulfonylureas for Type 2 Diabetes Sales by Country (2026-2031) & (K Units)
Table 44. Latin America Sulfonylureas for Type 2 Diabetes Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America Sulfonylureas for Type 2 Diabetes Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa Sulfonylureas for Type 2 Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa Sulfonylureas for Type 2 Diabetes Sales by Country (2020-2025) & (K Units)
Table 48. Middle East and Africa Sulfonylureas for Type 2 Diabetes Sales by Country (2026-2031) & (K Units)
Table 49. Middle East and Africa Sulfonylureas for Type 2 Diabetes Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa Sulfonylureas for Type 2 Diabetes Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global Sulfonylureas for Type 2 Diabetes Sales (K Units) by Type (2020-2025)
Table 52. Global Sulfonylureas for Type 2 Diabetes Sales (K Units) by Type (2026-2031)
Table 53. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Type (2020-2025)
Table 54. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Type (2026-2031)
Table 55. Global Sulfonylureas for Type 2 Diabetes Revenue (US$ Million) by Type (2020-2025)
Table 56. Global Sulfonylureas for Type 2 Diabetes Revenue (US$ Million) by Type (2026-2031)
Table 57. Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Type (2020-2025)
Table 58. Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Type (2026-2031)
Table 59. Global Sulfonylureas for Type 2 Diabetes Price (US$/Unit) by Type (2020-2025)
Table 60. Global Sulfonylureas for Type 2 Diabetes Price (US$/Unit) by Type (2026-2031)
Table 61. Global Sulfonylureas for Type 2 Diabetes Sales (K Units) by Application (2020-2025)
Table 62. Global Sulfonylureas for Type 2 Diabetes Sales (K Units) by Application (2026-2031)
Table 63. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Application (2020-2025)
Table 64. Global Sulfonylureas for Type 2 Diabetes Sales Market Share by Application (2026-2031)
Table 65. Global Sulfonylureas for Type 2 Diabetes Revenue (US$ Million) by Application (2020-2025)
Table 66. Global Sulfonylureas for Type 2 Diabetes Revenue (US$ Million) by Application (2026-2031)
Table 67. Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Application (2020-2025)
Table 68. Global Sulfonylureas for Type 2 Diabetes Revenue Market Share by Application (2026-2031)
Table 69. Global Sulfonylureas for Type 2 Diabetes Price (US$/Unit) by Application (2020-2025)
Table 70. Global Sulfonylureas for Type 2 Diabetes Price (US$/Unit) by Application (2026-2031)
Table 71. Sanofi Company Information
Table 72. Sanofi Description and Business Overview
Table 73. Sanofi Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 74. Sanofi Sulfonylureas for Type 2 Diabetes Product
Table 75. Sanofi Recent Developments/Updates
Table 76. Pfizer Company Information
Table 77. Pfizer Description and Business Overview
Table 78. Pfizer Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 79. Pfizer Sulfonylureas for Type 2 Diabetes Product
Table 80. Pfizer Recent Developments/Updates
Table 81. Teva Company Information
Table 82. Teva Description and Business Overview
Table 83. Teva Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. Teva Sulfonylureas for Type 2 Diabetes Product
Table 85. Teva Recent Developments/Updates
Table 86. AdvaCare Pharma Company Information
Table 87. AdvaCare Pharma Description and Business Overview
Table 88. AdvaCare Pharma Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 89. AdvaCare Pharma Sulfonylureas for Type 2 Diabetes Product
Table 90. AdvaCare Pharma Recent Developments/Updates
Table 91. Krka Company Information
Table 92. Krka Description and Business Overview
Table 93. Krka Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 94. Krka Sulfonylureas for Type 2 Diabetes Product
Table 95. Krka Recent Developments/Updates
Table 96. Lupin Healthcare Company Information
Table 97. Lupin Healthcare Description and Business Overview
Table 98. Lupin Healthcare Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Lupin Healthcare Sulfonylureas for Type 2 Diabetes Product
Table 100. Lupin Healthcare Recent Developments/Updates
Table 101. Viatris (Mylan) Company Information
Table 102. Viatris (Mylan) Description and Business Overview
Table 103. Viatris (Mylan) Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Viatris (Mylan) Sulfonylureas for Type 2 Diabetes Product
Table 105. Viatris (Mylan) Recent Developments/Updates
Table 106. Apotex Corporation Company Information
Table 107. Apotex Corporation Description and Business Overview
Table 108. Apotex Corporation Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Apotex Corporation Sulfonylureas for Type 2 Diabetes Product
Table 110. Apotex Corporation Recent Developments/Updates
Table 111. Hoechst Canada Company Information
Table 112. Hoechst Canada Description and Business Overview
Table 113. Hoechst Canada Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Hoechst Canada Sulfonylureas for Type 2 Diabetes Product
Table 115. Hoechst Canada Recent Developments/Updates
Table 116. Hikma Pharmaceuticals Company Information
Table 117. Hikma Pharmaceuticals Description and Business Overview
Table 118. Hikma Pharmaceuticals Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Hikma Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product
Table 120. Hikma Pharmaceuticals Recent Developments/Updates
Table 121. Servier Laboratories Company Information
Table 122. Servier Laboratories Description and Business Overview
Table 123. Servier Laboratories Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Servier Laboratories Sulfonylureas for Type 2 Diabetes Product
Table 125. Servier Laboratories Recent Developments/Updates
Table 126. Aurobindo Pharma Company Information
Table 127. Aurobindo Pharma Description and Business Overview
Table 128. Aurobindo Pharma Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Aurobindo Pharma Sulfonylureas for Type 2 Diabetes Product
Table 130. Aurobindo Pharma Recent Developments/Updates
Table 131. Zydus Cadila Healthcare Company Information
Table 132. Zydus Cadila Healthcare Description and Business Overview
Table 133. Zydus Cadila Healthcare Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Zydus Cadila Healthcare Sulfonylureas for Type 2 Diabetes Product
Table 135. Zydus Cadila Healthcare Recent Developments/Updates
Table 136. Accord Healthcare Company Information
Table 137. Accord Healthcare Description and Business Overview
Table 138. Accord Healthcare Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Accord Healthcare Sulfonylureas for Type 2 Diabetes Product
Table 140. Accord Healthcare Recent Developments/Updates
Table 141. Taj Pharma Company Information
Table 142. Taj Pharma Description and Business Overview
Table 143. Taj Pharma Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Taj Pharma Sulfonylureas for Type 2 Diabetes Product
Table 145. Taj Pharma Recent Developments/Updates
Table 146. Boehringer Ingelheim Company Information
Table 147. Boehringer Ingelheim Description and Business Overview
Table 148. Boehringer Ingelheim Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Boehringer Ingelheim Sulfonylureas for Type 2 Diabetes Product
Table 150. Boehringer Ingelheim Recent Developments/Updates
Table 151. Qingdao Double Whale Pharmaceutical Company Information
Table 152. Qingdao Double Whale Pharmaceutical Description and Business Overview
Table 153. Qingdao Double Whale Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Qingdao Double Whale Pharmaceutical Sulfonylureas for Type 2 Diabetes Product
Table 155. Qingdao Double Whale Pharmaceutical Recent Developments/Updates
Table 156. CHANGZHOU SUNLIGHT PHARMACEUTICAL Company Information
Table 157. CHANGZHOU SUNLIGHT PHARMACEUTICAL Description and Business Overview
Table 158. CHANGZHOU SUNLIGHT PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. CHANGZHOU SUNLIGHT PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Product
Table 160. CHANGZHOU SUNLIGHT PHARMACEUTICAL Recent Developments/Updates
Table 161. Zhejiang Shapuaisi Pharmaceutical Company Information
Table 162. Zhejiang Shapuaisi Pharmaceutical Description and Business Overview
Table 163. Zhejiang Shapuaisi Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Zhejiang Shapuaisi Pharmaceutical Sulfonylureas for Type 2 Diabetes Product
Table 165. Zhejiang Shapuaisi Pharmaceutical Recent Developments/Updates
Table 166. DISHA PHARMACEUTICAL GROUP Company Information
Table 167. DISHA PHARMACEUTICAL GROUP Description and Business Overview
Table 168. DISHA PHARMACEUTICAL GROUP Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. DISHA PHARMACEUTICAL GROUP Sulfonylureas for Type 2 Diabetes Product
Table 170. DISHA PHARMACEUTICAL GROUP Recent Developments/Updates
Table 171. Shandong Lukang Pharmaceutical Company Information
Table 172. Shandong Lukang Pharmaceutical Description and Business Overview
Table 173. Shandong Lukang Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. Shandong Lukang Pharmaceutical Sulfonylureas for Type 2 Diabetes Product
Table 175. Shandong Lukang Pharmaceutical Recent Developments/Updates
Table 176. Beijing Jingfeng pharmaceutical Company Information
Table 177. Beijing Jingfeng pharmaceutical Description and Business Overview
Table 178. Beijing Jingfeng pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 179. Beijing Jingfeng pharmaceutical Sulfonylureas for Type 2 Diabetes Product
Table 180. Beijing Jingfeng pharmaceutical Recent Developments/Updates
Table 181. Suzhou Zhonghua Pharmaceutical Industry Company Information
Table 182. Suzhou Zhonghua Pharmaceutical Industry Description and Business Overview
Table 183. Suzhou Zhonghua Pharmaceutical Industry Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 184. Suzhou Zhonghua Pharmaceutical Industry Sulfonylureas for Type 2 Diabetes Product
Table 185. Suzhou Zhonghua Pharmaceutical Industry Recent Developments/Updates
Table 186. Shanghai SINE United Pharmaceuticals Company Information
Table 187. Shanghai SINE United Pharmaceuticals Description and Business Overview
Table 188. Shanghai SINE United Pharmaceuticals Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 189. Shanghai SINE United Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product
Table 190. Shanghai SINE United Pharmaceuticals Recent Developments/Updates
Table 191. Zhuhai United Pharmaceutical Company Information
Table 192. Zhuhai United Pharmaceutical Description and Business Overview
Table 193. Zhuhai United Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 194. Zhuhai United Pharmaceutical Sulfonylureas for Type 2 Diabetes Product
Table 195. Zhuhai United Pharmaceutical Recent Developments/Updates
Table 196. Changzhou Siyao Pharmaceuticals Company Information
Table 197. Changzhou Siyao Pharmaceuticals Description and Business Overview
Table 198. Changzhou Siyao Pharmaceuticals Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 199. Changzhou Siyao Pharmaceuticals Sulfonylureas for Type 2 Diabetes Product
Table 200. Changzhou Siyao Pharmaceuticals Recent Developments/Updates
Table 201. Shijiazhuang Yiling Pharmaceutical Company Information
Table 202. Shijiazhuang Yiling Pharmaceutical Description and Business Overview
Table 203. Shijiazhuang Yiling Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 204. Shijiazhuang Yiling Pharmaceutical Sulfonylureas for Type 2 Diabetes Product
Table 205. Shijiazhuang Yiling Pharmaceutical Recent Developments/Updates
Table 206. Jiangsu Vanguard Pharmaceutical Company Information
Table 207. Jiangsu Vanguard Pharmaceutical Description and Business Overview
Table 208. Jiangsu Vanguard Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 209. Jiangsu Vanguard Pharmaceutical Sulfonylureas for Type 2 Diabetes Product
Table 210. Jiangsu Vanguard Pharmaceutical Recent Developments/Updates
Table 211. China Resources Shuanghe Pharmaceutical Company Information
Table 212. China Resources Shuanghe Pharmaceutical Description and Business Overview
Table 213. China Resources Shuanghe Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 214. China Resources Shuanghe Pharmaceutical Sulfonylureas for Type 2 Diabetes Product
Table 215. China Resources Shuanghe Pharmaceutical Recent Developments/Updates
Table 216. TIPR PHARMACEUTICAL Company Information
Table 217. TIPR PHARMACEUTICAL Description and Business Overview
Table 218. TIPR PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 219. TIPR PHARMACEUTICAL Sulfonylureas for Type 2 Diabetes Product
Table 220. TIPR PHARMACEUTICAL Recent Developments/Updates
Table 221. Jilin Jinheng Pharmaceutical Company Information
Table 222. Jilin Jinheng Pharmaceutical Description and Business Overview
Table 223. Jilin Jinheng Pharmaceutical Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 224. Jilin Jinheng Pharmaceutical Sulfonylureas for Type 2 Diabetes Product
Table 225. Jilin Jinheng Pharmaceutical Recent Developments/Updates
Table 226. Wanbang Biopharmaceuticals Company Information
Table 227. Wanbang Biopharmaceuticals Description and Business Overview
Table 228. Wanbang Biopharmaceuticals Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 229. Wanbang Biopharmaceuticals Sulfonylureas for Type 2 Diabetes Product
Table 230. Wanbang Biopharmaceuticals Recent Developments/Updates
Table 231. Cspc Holdings Company Company Information
Table 232. Cspc Holdings Company Description and Business Overview
Table 233. Cspc Holdings Company Sulfonylureas for Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 234. Cspc Holdings Company Sulfonylureas for Type 2 Diabetes Product
Table 235. Cspc Holdings Company Recent Developments/Updates
Table 236. Key Raw Materials Lists
Table 237. Raw Materials Key Suppliers Lists
Table 238. Sulfonylureas for Type 2 Diabetes Distributors List
Table 239. Sulfonylureas for Type 2 Diabetes Customers List
Table 240. Sulfonylureas for Type 2 Diabetes Market Trends
Table 241. Sulfonylureas for Type 2 Diabetes Market Drivers
Table 242. Sulfonylureas for Type 2 Diabetes Market Challenges
Table 243. Sulfonylureas for Type 2 Diabetes Market Restraints
Table 244. Research Programs/Design for This Report
Table 245. Key Data Information from Secondary Sources
Table 246. Key Data Information from Primary Sources
Table 247. Authors List of This Report
List of Figures
Figure 1. Product Picture of Sulfonylureas for Type 2 Diabetes
Figure 2. Global Sulfonylureas for Type 2 Diabetes Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sulfonylureas for Type 2 Diabetes Market Share by Type: 2024 & 2031
Figure 4. Glibenclamide Product Picture
Figure 5. Glipizide Product Picture
Figure 6. Gliclazide Product Picture
Figure 7. Glizidone Product Picture
Figure 8. Glimepiride Product Picture
Figure 9. Global Sulfonylureas for Type 2 Diabetes Market Value by Patent, (US$ Million) & (2020-2031)
Figure 10. Global Sulfonylureas for Type 2 Diabetes Market Share by Patent: 2024 VS 2031
Figure 11. Original Drug Product Picture
Figure 12. Generic Drug Product Picture
Figure 13. Global Sulfonylureas for Type 2 Diabetes Market Value by Application (2020-2031) & (US$ Million)
Figure 14. Global Sulfonylureas for Type 2 Diabetes Market Share by Application: 2024 & 2031
Figure 15. Hospital
Figure 16. Pharmacy
Figure 17. Global Sulfonylureas for Type 2 Diabetes Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Sulfonylureas for Type 2 Diabetes Market Size (2020-2031) & (US$ Million)
Figure 19. Global Sulfonylureas for Type 2 Diabetes Sales (2020-2031) & (K Units)
Figure 20. Global Sulfonylureas for Type 2 Diabetes Average Price (US$/Unit) & (2020-2031)
Figure 21. Sulfonylureas for Type 2 Diabetes Report Years Considered
Figure 22. Sulfonylureas for Type 2 Diabetes Sales Share by Manufacturers in 2024
Figure 23. Global Sulfonylureas for Type 2 Diabetes Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Sulfonylureas for Type 2 Diabetes Players: Market Share by Revenue in Sulfonylureas for Type 2 Diabetes in 2024
Figure 25. Sulfonylureas for Type 2 Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Sulfonylureas for Type 2 Diabetes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Sulfonylureas for Type 2 Diabetes Sales Market Share by Country (2020-2031)
Figure 28. North America Sulfonylureas for Type 2 Diabetes Revenue Market Share by Country (2020-2031)
Figure 29. United States Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Sulfonylureas for Type 2 Diabetes Sales Market Share by Country (2020-2031)
Figure 32. Europe Sulfonylureas for Type 2 Diabetes Revenue Market Share by Country (2020-2031)
Figure 33. Germany Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Sulfonylureas for Type 2 Diabetes Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Sulfonylureas for Type 2 Diabetes Revenue Market Share by Region (2020-2031)
Figure 40. China Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. China Taiwan Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Sulfonylureas for Type 2 Diabetes Sales Market Share by Country (2020-2031)
Figure 48. Latin America Sulfonylureas for Type 2 Diabetes Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Colombia Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Sulfonylureas for Type 2 Diabetes Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Sulfonylureas for Type 2 Diabetes Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Sulfonylureas for Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Sulfonylureas for Type 2 Diabetes by Type (2020-2031)
Figure 59. Global Revenue Market Share of Sulfonylureas for Type 2 Diabetes by Type (2020-2031)
Figure 60. Global Sulfonylureas for Type 2 Diabetes Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Sulfonylureas for Type 2 Diabetes by Application (2020-2031)
Figure 62. Global Revenue Market Share of Sulfonylureas for Type 2 Diabetes by Application (2020-2031)
Figure 63. Global Sulfonylureas for Type 2 Diabetes Price (US$/Unit) by Application (2020-2031)
Figure 64. Sulfonylureas for Type 2 Diabetes Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
